The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorCukurova University

About this trial

This research will determine the impact of optimizing dosage and storage conditions for indocyanine green on health outcomes and will contribute to improving treatment processes in gynecological cancers. Ultrastaging will increase the detection of micrometastases. Furthermore, the cost impact of these optimizations will be evaluated. It will help develop more effective, safe, and cost-effective methods for sentinel lymph node mapping in gynecological cancers. Furthermore, significant savings in healthcare costs could be achieved.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

cervical cancer, endometrial cancer, vulvar cancer, using indocyanine green, sentinel lymph node dissection

Disqualifiers

None

Trial population

Women who have endometrial or cervical or vulvar cancer

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Sentinel lymph node detection success rate associated with optimized indocyanine green (ICG) dosage and storage conditions.

Time frame
Baseline (pre-procedure), perioperative/periprocedural period, and up to 24 weeks post-procedure.

Secondary outcomes

1

Impact of optimizing indocyanine green (ICG) dosage and storage conditions on total procedural cost.

Time frame
Baseline (pre-procedure) and up to 24 weeks post-procedure.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.